SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+2.97%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$1.09B
AUM Growth
+$1.09B
(+13%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
14.49%
Top 10 Holdings %
Top 10 Hldgs %
43.03%
Holding
204
New
91
Increased
35
Reduced
20
Closed
37
Top Buys
| 1 |
Sanofi
SNY
|
$49.4M |
| 2 |
AbbVie
ABBV
|
$28.1M |
| 3 |
Johnson & Johnson
JNJ
|
$19M |
| 4 |
LivePerson
LPSN
|
$13.7M |
| 5 |
AstraZeneca
AZN
|
$13.4M |
Top Sells
| 1 |
Novartis
NVS
|
$40.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
$26.8M |
| 3 |
Sarepta Therapeutics
SRPT
|
$12.8M |
| 4 |
Zymeworks
ZYME
|
$11.6M |
| 5 |
Meta Platforms (Facebook)
META
|
$10.9M |
Sector Composition
| 1 | Healthcare | 74.93% |
| 2 | Technology | 9.21% |
| 3 | Industrials | 5.88% |
| 4 | Financials | 3.51% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ascendis Pharma
ASND
$12.1B
| – | – |
-23,599
| Closed | -$3.94M |
|
202
Aligos Therapeutics
ALGS
$75.1M
| – | – |
-74,000
| Closed | -$2.05M |
|
203
Aclaris Therapeutics
ACRS
$223M
| – | – |
-150,000
| Closed | -$971K |
|